Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

Zoledronic Acid 3Morphine 3Analgesia 3Surveys and Questionnaires 2Oxycodone 2Music Therapy 2Fentanyl 2oxycodone-acetaminophen 1Uncertainty 1Sodium Bicarbonate 1Saline Solution 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Pamidronate 1Methadone 1Ketorolac Tromethamine 1Ketorolac 1Ketamine 1Interviews as Topic 1Exercise 1Early Intervention, Educational 1Dextromethorphan 1Cognitive Behavioral Therapy 1Behavior Therapy 1Baclofen 1Acupuncture Therapy 1Acetaminophen 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Baclofen × Plasma cell × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡